Table 4.
Variable | Cameroon | CDI | Ghana | Kenya | Mali | Niger |
---|---|---|---|---|---|---|
Recent training* | −3.790† | 8.332‡ | NA§ | NAǁ | 1.279† | NAǁ |
Job aids* | 5.982† | 8.882¶ | NA§ | 10.75† | 0.141† | 8.729† |
Provider gender* | 4.284† | 4.190† | NA§ | NAǁ | NAǁ | 3.161† |
Cadre* | ||||||
Nurses | Ref. | Ref. | NA§ | NAǁ | NAǁ | Ref. |
Midwives | −10.284† | 1.101† | NA§ | NAǁ | NAǁ | 1.519† |
Nurse assistants | 1.238† | NAǁ | NA§ | NAǁ | NAǁ | NAǁ |
Facility type* | ||||||
Dispensaries | NA# | Ref. | NA§ | Ref. | NA** | NA** |
Health centers | NA# | −5.581† | NA§ | 1.517† | NA** | NA** |
Hospitals | NA# | 3.176† | NA§ | −2.662† | NA** | NA** |
CDI = Cote d’Ivoire; NA = not applicable; Ref. = reference value.
The effect of artemisinin-based combination therapy stock availability is held constant.
Not significant
P <0.05.
Ghana does not have treatment competency score data.
No available data.
P <0.01.
Observation sample sizes were widely disparate in Cameroon (health centers, n = 328; hospitals, n = 11).
Mali and Niger only have observations at the health center facility level.